Matthew Buten - Dec 8, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Officer
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 07:52 PM
Next filing
Jan 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award +50K 50K Dec 8, 2021 Common Shares 50K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 50,000 restricted share units on December 8, 2021. 12,500 of the restricted share units vested on December 8, 2021 and are subject to deferred settlement. The remainder vest in three equal installments on December 8, 2022, 2023 and 2024 subject to the reporting person's continued service with the issuer at each vesting date.
F3 Not applicable.